Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Treatment Preferences of urologists in Great Britain and Ireland in the management of prostate cancer

Tools
- Tools
+ Tools

Waymont, B., Lynch, T. H., Dunn, Janet A., Bathers, S. and Wallace, D. M. A. (1993) Treatment Preferences of urologists in Great Britain and Ireland in the management of prostate cancer. British Journal of Urology, 71 (5). pp. 577-582. doi:10.1111/j.1464-410X.1993.tb16028.x

Research output not available from this repository, contact author.
Official URL: https://doi.org/10.1111/j.1464-410X.1993.tb16028.x

Request Changes to record.

Abstract

A questionnaire was sent to all full‐time British and Irish urologists (n=278) on the management of prostate cancer and was answered by 229 (82%). The questions included 3 specific clinical situations, namely the management of incidental disease, the timing of treatment for metastatic disease and the mode of hormonal manipulation used for advanced disease.

It was found that 79% of urologists preferred a deferred treatment policy for incidental disease in the over‐75 age group. Radical prostatectomy was advocated by 10% of those questioned for patients in the under‐60 age group. Radiotherapy was the mainstay of treatment for incidental disease in the poorer prognosis groups of incidental disease, namely younger patients with more aggressive tumours.

Most urologists treated patients with asymptomatic metastatic disease at the time of diagnosis, with 18% entering patients into the Medical Research Council trial comparing immediate with deferred therapy.

Orchiectomy was advocated by 57% of urologists as their first‐line treatment for patients where hormonal manipulation was indicated. Consequently orchiectomy should remain the “gold standard” in comparative phase III trials in advanced prostate cancer.

Item Type: Journal Article
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine > Warwick Medical School > Health Sciences > Clinical Trials Unit
Faculty of Medicine > Warwick Medical School > Health Sciences
Faculty of Medicine > Warwick Medical School
Journal or Publication Title: British Journal of Urology
Publisher: Blackwell Science Ltd.
ISSN: 0007-1331
Official Date: 1 May 1993
Dates:
DateEvent
1 May 1993Published
Volume: 71
Number: 5
Page Range: pp. 577-582
DOI: 10.1111/j.1464-410X.1993.tb16028.x
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us